The effect of caffeine on the pharmacokinetics of acetaminophen in man. 1995

N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.

The influence of caffeine (60 mg) was studied on the pharmacokinetic characteristics of acetaminophen (500 mg single dose) in ten healthy male human volunteers in a complete cross-over design. A high-performance liquid chromatography (HPLC) method was used to analyse serum drug concentrations. Caffeine caused a highly significant (p < 0.01) increase in AUC and AUMC, a significant (p < 0.05) increase in Cmax, and a significant (p < 0.05) decrease in clearance (C1/F) of acetaminophen. We conclude that caffeine taken in doses commonly available commercially or in a cup of coffee can significantly potentiate the therapeutic potential of acetaminophen in man.

UI MeSH Term Description Entries
D008297 Male Males
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003069 Coffee A beverage made from ground COFFEA beans (SEEDS) infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
July 1981, Journal of clinical pharmacology,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
April 1984, Journal of clinical pharmacology,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
April 1983, Clinical pharmacology and therapeutics,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
October 1974, Journal of pharmacokinetics and biopharmaceutics,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
January 1981, Biopharmaceutics & drug disposition,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
April 1996, The Journal of pharmacology and experimental therapeutics,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
January 1981, European journal of clinical pharmacology,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
January 1981, European journal of clinical pharmacology,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
February 1966, Arztliche Forschung,
N Iqbal, and B Ahmad, and K H Janbaz, and A U Gilani, and S K Niazi
June 1983, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!